News

As the two Trump administration drug pricing deals find their place in the books and more that are likely on the way, the U.S. policy environment can very well soon stabilize for many Big Pharma companies. All this puts...

In a time when sustainability and environmental consciousness are at the forefront of our global priorities, industries seek greener and cleaner energy solutions. The pharmaceutical sector is a vital community industry responsible for advancing healthcare and improving lives. It...

It is well to be noted that in 2025, a minimum of 14 major pharmaceutical companies across the world went ahead and announced plans to broaden their manufacturing presence in the U.S. so as to lessen the supply chain...

Pharmaceutical manufacturing environments handle a variety of sensitive and potentially hazardous materials every day. These include solvents, flammable chemicals, pressurized gases, and high-temperature equipment, all of which can pose serious fire risks if not properly managed. Ensuring effective fire...

As the U.S. production investments continue to roll in 2025, LTS Lohmann, the German pharmaceutical technology specialist, is joining the table with a deal to boost its CDMO firepower in the U.S. Like many other contract manufacturing expansions that have...

As originally reported by the Straits Times and also shared by Reuters, the enforcement of US tariffs on pharma exports from Singapore is being deferred so as to provide stakeholders ample time to work out an amicable deal with the US...

Rachel Reeves, the UK Chancellor of the Exchequer, has asked more pharma investment coming in Britain, even as she doubles down on the commitment by the government when it comes to competitive drug pricing. Speaking to the reporters on the...